{"uri":"Anti-Neu5Gc-Antibody-Kit-Protocols-e25bgg6","version_id":"0","protocol_name":"Anti-Neu5Gc Antibody Kit Protocols","protocol_name_html":"Anti-Neu5Gc Antibody Kit Protocols","is_prepublished":"0","can_edit":"0","parent_id":null,"api_version":"1","is_new_mode":"1","last_modified":"1510247633","type_id":"3","link":"http:\/\/www.biolegend.com\/media_assets\/support_protocol\/Neu5Gc_Antibody_Kit_Protocols_110813.pdf","fork_id":"","public_fork_note":"","number_of_steps":"3","has_versions":"1","first_published_date":"1465228209","publish_date":"2016-06-06 15:50:09","documents":null,"have_protocol_in_step":"0","is_protocol_in_step":"0","vendor_name":"Contributed by users","vendor_link":"https:\/\/www.protocols.io","vendor_logo":"\/img\/vendors\/1.png","mod_mins":"-45","mod_secs":"1","description":"<p>Anti-Neu5Gc Antibody Kit Protocols for Flow Cytometry, ELISA, and Western blot.<\/p>","is_bookmarked":"0","can_reassign":"1","before_start":null,"has_guidelines":"0","materials":[],"warning":null,"version_class":"2877","public":"1","is_owner":"1","is_original_owner":"1","created_on":"1464986813","protocol_affiliation":"BioLegend","affiliation":"BioLegend","doi":"dx.doi.org\/10.17504\/protocols.io.e25bgg6","doi_status":"2","changed_fork_steps":null,"profile_url":"Kelsey-w2z29423v2","protocol_img":"https:\/\/s3.amazonaws.com\/pr-journal\/jr3bjf6.jpg","profile_image":"https:\/\/s3.amazonaws.com\/pr-journal\/jikecje.jpg","full_name":"Kelsey Knight","created_by":"Kelsey Knight","private_link":"85897E7D39257077C3370FC19239B3A0","original_img":"1","username":"kelsey-knight","is_retracted":"0","retraction_reason":null,"plos_id":null,"manuscript_citation":null,"journal_name":null,"is_donations_disabled":"0","is_donations_disabled_by_user":"9","item_record_id":229099,"fork_info":[],"compare_forks":[],"protocols":[{"protocol_name":"Anti-Neu5Gc Antibody Kit Protocol - ELISA","protocol_name_html":"Anti-Neu5Gc Antibody Kit Protocol - ELISA","protocol_id":"2879","version_id":"0","last_modified":"1521612662","link":"http:\/\/www.biolegend.com\/media_assets\/support_protocol\/Neu5Gc_Antibody_Kit_Protocols_110813.pdf","fork_id":null,"number_of_steps":"9","vendor_id":"1","downloads":"0","views":"32","uri":"Anti-Neu5Gc-Antibody-Kit-Protocol-ELISA-e27bghn","description":"<p>This protocol is essentially the same as a standard ELISA protocol, with one major exception \u2013 all animal compounds must be avoided in buffers, etc. because they contain Neu5Gc, which will interfere with antibody activity and result in misleading data. Essentially, the glycoconjugate to be evaluated is immobilized on an ELISA plate and exposed to a primary antibody. The antibody provided in this kit has been shown to identify as little as 5 pmol of Neu5Gc per microgram glycoprotein, which is at or below the current detection limit for conventional DMB HPLC analysis. An advantage of the ELISA procedure is that it confirms the presence of Neu5Gc on the glycoconjugate of interest, but use caution, as it also reacts with solution\/media that contains glycoconjugate.<\/p>","public":"1","created_on":"1464987967","first_published_date":"2016-06-06 15:50:09","authors":"Kelsey Miller","has_guidelines":"1","has_warning":"0","has_before_start":"0","protocol_affiliation":"BioLegend","doi":"dx.doi.org\/10.17504\/protocols.io.e27bghn","doi_status":"2","type_id":"1","created_by":"Kelsey Knight","is_bookmarked":"0","affiliation":"BioLegend","username":"kelsey-knight","first_name":"Kelsey","last_name":"Knight","profile_image":"https:\/\/s3.amazonaws.com\/pr-journal\/jikecje.jpg","protocol_img":"https:\/\/s3.amazonaws.com\/pr-journal\/jr3bjf6.jpg","groups":[{"group_id":"179","group_uri":"biolegend","group_name":"BioLegend","group_logo":"https:\/\/s3.amazonaws.com\/pr-journal\/jr3bjf6.jpg","requested_uid":null,"request_flag":null,"my_request":"1"}],"versions":[{"protocol_id":"2879","protocol_name":"Anti-Neu5Gc Antibody Kit Protocol - ELISA","protocol_name_html":"Anti-Neu5Gc Antibody Kit Protocol - ELISA","protocol_img":"https:\/\/s3.amazonaws.com\/pr-journal\/jr3bjf6.jpg","user_id":"0","uri":"Anti-Neu5Gc-Antibody-Kit-Protocol-ELISA-e27bghn","version_id":"0","date_created":"2016-06-03 21:06:07","created_on":"1464987967","published_on":"1465228209","full_name":"Kelsey Knight","username":"kelsey-knight","affiliation":"BioLegend","profile_image":"https:\/\/s3.amazonaws.com\/pr-journal\/jikecje.jpg","has_access":"1"},{"protocol_id":"5775","protocol_name":"Anti-Neu5Gc Antibody Kit Protocol - ELISA","protocol_name_html":"Anti-Neu5Gc Antibody Kit Protocol - ELISA","protocol_img":"https:\/\/s3.amazonaws.com\/pr-journal\/jr3bjf6.jpg","user_id":"0","uri":"anti-neu5gc-antibody-kit-protocol-elisa-hvpb65n","version_id":"1","date_created":"2017-05-08 23:23:01","created_on":"1494285781","published_on":"1494285845","full_name":"Kelsey Knight","username":"kelsey-knight","affiliation":"BioLegend","profile_image":"https:\/\/s3.amazonaws.com\/pr-journal\/jikecje.jpg","has_access":"1"}],"forks_count":{"public":"0","private":"0"}},{"protocol_name":"Anti-Neu5Gc Antibody Kit Protocol - Flow Cytometry","protocol_name_html":"Anti-Neu5Gc Antibody Kit Protocol - Flow Cytometry","protocol_id":"2878","version_id":"0","last_modified":"1522044662","link":"http:\/\/www.biolegend.com\/media_assets\/support_protocol\/Neu5Gc_Antibody_Kit_Protocols_110813.pdf","fork_id":null,"number_of_steps":"11","vendor_id":"1","downloads":"0","views":"104","uri":"Anti-Neu5Gc-Antibody-Kit-Protocol-Flow-Cytometry-e26bghe","description":"<p>Anti-Neu5Gc may be used for staining cells prior to analysis by Flow Cytometry. This kit contains all the essential components needed to identify Neu5Gc on the surface of cells by flow cytometry.<\/p>\n<p>\u00a0<\/p>\n<p>Use of the blocking agent (Neu5Gc Assay Blocking Solution) provided in the kit is essential, as commonly used blocking agents invariably contain serum, or serum components, that can either inhibit detection or introduce Neu5Gc contamination.<\/p>\n<p>\u00a0<\/p>\n<p>Tissue culture-grown CHO-K1 can be used as a positive control, and human peripheral blood mononuclear cells serve as a negative control. Adherent tissue culture-grown cells should be released from the culture flasks by using 5-10mM EDTA for 10 minutes at room temperature. Other non-enzymatic methods, such as Accutase, may be used. Immediately wash cells in blocking buffer that contains a lower concentration of EDTA, and resuspend cells in blocking buffer to determine cell numbers and viability.<\/p>","public":"1","created_on":"1464986934","first_published_date":"2016-06-06 15:50:11","authors":"Kelsey Miller","has_guidelines":"1","has_warning":"0","has_before_start":"0","protocol_affiliation":"BioLegend","doi":"dx.doi.org\/10.17504\/protocols.io.e26bghe","doi_status":"2","type_id":"1","created_by":"Kelsey Knight","is_bookmarked":"0","affiliation":"BioLegend","username":"kelsey-knight","first_name":"Kelsey","last_name":"Knight","profile_image":"https:\/\/s3.amazonaws.com\/pr-journal\/jikecje.jpg","protocol_img":"https:\/\/s3.amazonaws.com\/pr-journal\/jr3bjf6.jpg","groups":[{"group_id":"179","group_uri":"biolegend","group_name":"BioLegend","group_logo":"https:\/\/s3.amazonaws.com\/pr-journal\/jr3bjf6.jpg","requested_uid":null,"request_flag":null,"my_request":"1"}],"versions":[{"protocol_id":"2878","protocol_name":"Anti-Neu5Gc Antibody Kit Protocol - Flow Cytometry","protocol_name_html":"Anti-Neu5Gc Antibody Kit Protocol - Flow Cytometry","protocol_img":"https:\/\/s3.amazonaws.com\/pr-journal\/jr3bjf6.jpg","user_id":"0","uri":"Anti-Neu5Gc-Antibody-Kit-Protocol-Flow-Cytometry-e26bghe","version_id":"0","date_created":"2016-06-03 20:48:54","created_on":"1464986934","published_on":"1465228211","full_name":"Kelsey Knight","username":"kelsey-knight","affiliation":"BioLegend","profile_image":"https:\/\/s3.amazonaws.com\/pr-journal\/jikecje.jpg","has_access":"1"},{"protocol_id":"5776","protocol_name":"Anti-Neu5Gc Antibody Kit Protocol - Flow Cytometry","protocol_name_html":"Anti-Neu5Gc Antibody Kit Protocol - Flow Cytometry","protocol_img":"https:\/\/s3.amazonaws.com\/pr-journal\/jr3bjf6.jpg","user_id":"0","uri":"anti-neu5gc-antibody-kit-protocol-flow-cytometry-hvqb65w","version_id":"1","date_created":"2017-05-08 23:24:45","created_on":"1494285885","published_on":"1494285909","full_name":"Kelsey Knight","username":"kelsey-knight","affiliation":"BioLegend","profile_image":"https:\/\/s3.amazonaws.com\/pr-journal\/jikecje.jpg","has_access":"1"}],"forks_count":{"public":"0","private":"0"}},{"protocol_name":"Anti-Neu5Gc Antibody Kit Protocol - Western blot","protocol_name_html":"Anti-Neu5Gc Antibody Kit Protocol - Western blot","protocol_id":"2880","version_id":"0","last_modified":"1520489461","link":"http:\/\/www.biolegend.com\/media_assets\/support_protocol\/Neu5Gc_Antibody_Kit_Protocols_110813.pdf","fork_id":null,"number_of_steps":"12","vendor_id":"1","downloads":"0","views":"32","uri":"Anti-Neu5Gc-Antibody-Kit-Protocol-Western-blot-e28bghw","description":"<p>The Anti-Neu5Gc Antibody Kit contains the essential monospecific polyclonal chicken IgY antibody, along with a negative control primary antibody to detect the presence of Neu5Gc on glycoconjugates by Western blot (WB). Samples to be evaluated are first subjected to SDS-PAGE, followed by transfer to a nitrocellulose or polyvinylidenedifluoride (PVDF) membrane. The membrane is then incubated with affinity-purified polyclonal anti-Neu5Gc to determine the presence of Neu5Gc on the protein of interest.<\/p>\n<p>\u00a0<\/p>\n<p>The antibody provided in this kit has been shown to identify as little as 5 pmol of Neu5Gc per ug glycoprotein, which is at or below the current detection limit for conventional analysis by acid release, purification, DMB derivatization, HPLC, and electrospray mass-spectrometry. The Western blot provides additional information in that it confirms that Neu5G is directly linked to the glycoprotein of interest rather than to an accompanying sample component.<\/p>","public":"1","created_on":"1464988687","first_published_date":"2016-06-06 15:50:12","authors":"Kelsey Miller","has_guidelines":"1","has_warning":"0","has_before_start":"0","protocol_affiliation":"BioLegend","doi":"dx.doi.org\/10.17504\/protocols.io.e28bghw","doi_status":"2","type_id":"1","created_by":"Kelsey Knight","is_bookmarked":"0","affiliation":"BioLegend","username":"kelsey-knight","first_name":"Kelsey","last_name":"Knight","profile_image":"https:\/\/s3.amazonaws.com\/pr-journal\/jikecje.jpg","protocol_img":"https:\/\/s3.amazonaws.com\/pr-journal\/jr3bjf6.jpg","groups":[{"group_id":"179","group_uri":"biolegend","group_name":"BioLegend","group_logo":"https:\/\/s3.amazonaws.com\/pr-journal\/jr3bjf6.jpg","requested_uid":null,"request_flag":null,"my_request":"1"}],"versions":[{"protocol_id":"2880","protocol_name":"Anti-Neu5Gc Antibody Kit Protocol - Western blot","protocol_name_html":"Anti-Neu5Gc Antibody Kit Protocol - Western blot","protocol_img":"https:\/\/s3.amazonaws.com\/pr-journal\/jr3bjf6.jpg","user_id":"0","uri":"Anti-Neu5Gc-Antibody-Kit-Protocol-Western-blot-e28bghw","version_id":"0","date_created":"2016-06-03 21:18:07","created_on":"1464988687","published_on":"1465228212","full_name":"Kelsey Knight","username":"kelsey-knight","affiliation":"BioLegend","profile_image":"https:\/\/s3.amazonaws.com\/pr-journal\/jikecje.jpg","has_access":"1"},{"protocol_id":"5777","protocol_name":"Anti-Neu5Gc Antibody Kit Protocol - Western Blot","protocol_name_html":"Anti-Neu5Gc Antibody Kit Protocol - Western Blot","protocol_img":"https:\/\/s3.amazonaws.com\/pr-journal\/jr3bjf6.jpg","user_id":"0","uri":"anti-neu5gc-antibody-kit-protocol-western-blot-hvrb656","version_id":"1","date_created":"2017-05-08 23:25:45","created_on":"1494285945","published_on":"1494285991","full_name":"Kelsey Knight","username":"kelsey-knight","affiliation":"BioLegend","profile_image":"https:\/\/s3.amazonaws.com\/pr-journal\/jikecje.jpg","has_access":"1"}],"forks_count":{"public":"0","private":"0"}}],"groups":[{"group_id":"179","group_uri":"biolegend","group_name":"BioLegend","group_logo":"https:\/\/s3.amazonaws.com\/pr-journal\/jr3bjf6.jpg","requested_uid":null,"request_flag":null,"my_request":"1"}],"number_of_shared_runs":[],"ownership_history":[],"keywords":"","transfer_to_user":[],"sub_transfer":false,"is_transfer_pending":false,"number_of_bookmarks":"0","collections":[],"tags":[],"archived":0,"sub_authors":[],"sub_protocols_number":0,"can_edit_shared":0,"shared_runs":[],"is_shared_run":0,"is_shared":1,"banner":null,"contact_badges":[{"badge_id":"4","badge_image":"\/img\/badges\/gold.svg","badge_description":"Gold power author!"},{"badge_id":"5","badge_image":"\/img\/badges\/earlyadopter.svg","badge_description":"Early adopter"},{"badge_id":"6","badge_image":"\/img\/badges\/socialbutterfly.svg","badge_description":"Social butterfly"}],"number_of_comments":0,"big_protocol_img":"https:\/\/s3.amazonaws.com\/pr-journal\/jr2bjf6.jpg","big_protocol_img_ofn":"biolegend_square_logo_nocom.jpg","is_locked":0,"is_locked_by":false,"authors":"Kelsey Miller","authors_list":[{"name":"Kelsey Miller","affiliation":"BioLegend","username":null,"profile_image":null}],"user":{"profile_image":"https:\/\/s3.amazonaws.com\/pr-journal\/jikecje.jpg","username":"kelsey-knight","full_name":"Kelsey Knight","created_by":"Kelsey Knight"},"access":{"can_view":"1","can_remove":"0","can_add":"0","can_edit":0,"can_publish":0,"can_get_doi":0,"can_share":"0","can_move":"1","can_transfer":"1","can_download":"1","is_locked":"0"},"is_contact_suspended":0,"guidelines":null,"status_id":"1","is_research":"1","status_info":null,"steps":[]}